AbbVie and RemeGen enter into $5.6 billion oncology deal. This agreement is the first to be announced at the J.P. conference. Morgan Healthcare Conference in 2026. More deals are expected in the coming days. The agreement focuses on oncology treatments. The conference takes place in 2026. These partnerships strengthen the positions of companies in the market for anticancer drugs.